Immunotherapy News and Research

Latest Immunotherapy News and Research

Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19

A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.

12 May 2020

Too little sleep can negatively impact adults with asthma

A good night's sleep is crucial to good health. A new article in Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology reveals that too little sleep, and occasionally too much sleep, can negatively impact adults with asthma.

12 May 2020

Microbiome controls the fitness of our immune system

Working alongside colleagues in Mainz, Bern, Hannover and Bonn, researchers from Charité - Universitätsmedizin Berlin, the Berlin Institute of Health and the German Rheumatism Research Center Berlin were able to show how the microbiome helps to render the immune system capable of responding to pathogens.

11 May 2020

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Unprecedented collaboration and resources will be required to research and develop safe and effective vaccines for COVID-19 that can be manufactured and delivered in the scale of billions of doses to people globally.

11 May 2020

Indiana researchers identify new target for colorectal cancer immunotherapy

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a target for colorectal cancer immunotherapy.

11 May 2020

Finnish research in cancer immunotherapy receives 10 million euros

Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland's Personalized Health Program.

11 May 2020

New high-yield method for efficient production of birch pollen allergen for Immunotherapy

Allergies can significantly affect health and quality of life. While allergen immunotherapy provides long-lasting therapeutic relief to people suffering from environmental allergies, the therapy can last several years and requires large amounts of allergen.

11 May 2020

Neutralizing SARS-CoV-2 via S protein

A new study published on the preprint server bioRxiv* in May 2020 reports on a method to block severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by destroying its main spike protein, which is responsible for attachment to the host cell membrane.

10 May 2020

More selective elimination of leukemic and hematopoietic stem cells

Acute myeloid leukemia is an aggressive cancer of the blood-forming system. It affects the hematopoietic stem cells, or blood stem cells, of various white blood cells and of the red blood cells and platelets.

8 May 2020

EULAR publishes recommendations for management of rheumatic immune-related adverse events

The European League Against Rheumatism, EULAR, has published recommendations around rheumatic immune-related adverse events caused by cancer treatment with checkpoint inhibitors.

8 May 2020

Antibodies from llamas may hold cure for novel coronavirus SARS-CoV-2

As scientists across the globe race to find an effective treatment for the novel coronavirus, a team of scientists believe that a four-year-old llama named Winter may hold the key to fight the coronavirus disease (COVID-19).

7 May 2020

IONTAS announces a new collaboration to identify novel immunotherapy targets

Antibody discovery agreement will support the development of new therapeutics for acute and chronic inflammatory syndromes.

From FairJourney Biologics 7 May 2020

Arrayjet develops COVID-19 antibody screening technology to facilitate vaccine development

Arrayjet Limited, the Scottish-based bio-printing technology specialist for the life sciences industry, has re-purposed its in-house antibody screening technology to create a population-scale diagnostic program that will help scientists better understand the behavior of the Covid-19 virus and further the rapidity of a global vaccination program.

7 May 2020

Interleukin-12 electroporation led to clinical responses in patients with advanced melanoma

Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.

6 May 2020

Scientists develop a highly sensitive COVID-19 diagnostic platform

Cima Universidad de Navarra researchers have developed a large-scale, highly sensitive COVID-19 diagnostic platform more efficient than the commercial PCR test kits currently available.

4 May 2020

Activation of estrogen receptor can impede growth of pancreatic cancer cells

Activating the G protein-coupled estrogen receptor - a receptor found on the surface of many normal and cancer tissues - has been shown to stop pancreatic cancer from growing, but may also make tumors more visible to the immune system and thus more susceptible to modern immunotherapy.

4 May 2020

Lipo-ImmunoTech receives grant to develop novel adoptive cell therapy technology for cancer

Lipo-ImmunoTech, LLC, a startup based in Charleston, South Carolina, recently received a Phase I Small Business Technology Transfer grant of just over $224,000 to continue to develop its novel adoptive cell therapy technology for cancer.

2 May 2020

New math model predicts clinical outcomes in cancer patients treated with immunotherapy

A group of our cancer and mathematics researchers at Houston Methodist have developed a clinically-applicable mathematical model to predict patient outcomes to cancer immunotherapy.

30 Apr 2020

Drug combo for untreated CLL approved by FDA based on E1912 trial

Patients with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma now have a new treatment option--a combination of the targeted agent ibrutinib with the immunologic agent rituximab.

29 Apr 2020

Researchers discover cause for the lack of immune defense against tumors

One of the reasons why cancer develops is because regulatory cells inhibit the body's immune defense. Researchers under the helm of the Technical University of Munich have discovered a mechanism for identifying regulatory cells in tumor tissue that suppress an immune response.

29 Apr 2020

Immunotherapy News and Research

Latest Immunotherapy News and Research

Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19

Too little sleep can negatively impact adults with asthma

Microbiome controls the fitness of our immune system

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Indiana researchers identify new target for colorectal cancer immunotherapy

Finnish research in cancer immunotherapy receives 10 million euros

New high-yield method for efficient production of birch pollen allergen for Immunotherapy

Neutralizing SARS-CoV-2 via S protein

More selective elimination of leukemic and hematopoietic stem cells

EULAR publishes recommendations for management of rheumatic immune-related adverse events

Antibodies from llamas may hold cure for novel coronavirus SARS-CoV-2

IONTAS announces a new collaboration to identify novel immunotherapy targets

Arrayjet develops COVID-19 antibody screening technology to facilitate vaccine development

Interleukin-12 electroporation led to clinical responses in patients with advanced melanoma

Scientists develop a highly sensitive COVID-19 diagnostic platform

Activation of estrogen receptor can impede growth of pancreatic cancer cells

Lipo-ImmunoTech receives grant to develop novel adoptive cell therapy technology for cancer

New math model predicts clinical outcomes in cancer patients treated with immunotherapy

Drug combo for untreated CLL approved by FDA based on E1912 trial

Researchers discover cause for the lack of immune defense against tumors

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in